
Evotec and Novo Nordisk’s LAB eN² Selects First Projects for Translational Drug Discovery
Evotec and Novo Nordisk’s joint translational drug discovery initiative, LAB eN², has announced the selection of its first three research projects and an expansion to include five more leading academic institutions. LAB eN², launched in September 2023, aims to bridge